In:
Current Drug Metabolism, Bentham Science Publishers Ltd., Vol. 21, No. 6 ( 2020-09-25), p. 471-478
Abstract:
Green tea can inhibit OATPs, so it may interact with the substrate of OATPs, such as
rosuvastatin. Objective: This study aimed to investigate the effects of green tea on the pharmacokinetics of rosuvastatin and its
mechanism. Methods: Male Sprague-Dawley rats received different doses of green tea extract (GTE) and (-)- epigallocatechin-3-
gallate (EGCG). Caco-2 cells and OATP1B1-HEK293T cells were used in drug uptake and transport assay. The matrix concentrations of rosuvastatin and catechins were determined by ultra-performance liquid chromatographytandem
mass spectrometry (UPLC-MS/MS). Results: GTE and EGCG were both found to increase the area under the plasma concentration-time curve (AUC0-∞)
of rosuvastatin ((p 〈 0.050). In the Caco-2 cell model, the uptake and transport of rosuvastatin in the GTE groups were
1.94-fold (p 〈 0.001) and 2.11-fold (p 〈 0.050) higher, respectively, than those of the control group. However, in the
EGCG group, the uptake and transport of rosuvastatin were decreased by 22.62% and 44.19%, respectively (p 〈 0.050). In the OATP1B1- HEK293T cell model, the OATP1B1-mediated rosuvastatin uptake was decreased by
GTE to 35.02% of that in the control (p 〈 0.050) and was decreased by EGCG to 45.61% of that in the control
(p 〈 0.050). Conclusion: GTE increased the systemic rosuvastatin exposure in rats. The mechanism may include an increase in
rosuvastatin absorption and a decrease in liver distribution by inhibiting OATP1B1. EGCG may be the main ingredient of green tea that affects the pharmacokinetic parameters of rosuvastatin. Our results showed the
importance of conducting green tea-rosuvastatin study.
Type of Medium:
Online Resource
ISSN:
1389-2002
DOI:
10.2174/1389200221666200514133355
Language:
English
Publisher:
Bentham Science Publishers Ltd.
Publication Date:
2020
SSG:
15,3
Bookmarklink